Home | All trials

[RDF data]
Trial NCT00000206

Resource URI: http://static.linkedct.org/resource/trials/NCT00000206
PropertyValue
linkedct:brief_title Clinical Rescue Protocol - 2
linkedct:condition <http://static.linkedct.org/resource/condition/9249>
linkedct:criteria Inclusion Criteria: M/F ages 21-50. Opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 50 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000206
rdfs:label Trial NCT00000206
linkedct:lastchanged_date August 16, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/209856>
linkedct:nct_id NCT00000206
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Clinical Rescue Protocol
linkedct:org_study_id NIDA-06082-2
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/60742>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000206>
linkedct:phase Phase 2
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/14361>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/14363>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/1507>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/19100>
linkedct:reference <http://static.linkedct.org/resource/reference/3432>
linkedct:secondary_id R18-06082-2
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date April 1991
linkedct:study_design Treatment, Double-Blind
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to detect increasing medication dose results in heroin cessation for patients still using, to determine if decreasing medication dose in patients unable to tolerate medication dose increases retention, and to determine if blood levels of methadone or buprenorphine correlate with clinical response.
rdf:type linkedct:trials
linkedct:verification_date November 1993